David Landman
About David Landman
Independent director since January 24, 2023; age 69 (Class III, term through 2027). Senior Adviser at Perella Weinberg Partners (since 2016), formerly Partner and COO/Head of Capital Markets Advisory at PWP; previously Managing Director at Morgan Stanley International (1987–2006) and Associate Attorney at White & Case. Education: J.D./M.B.A., University of Chicago (Law School and Booth School of Business); A.B., Wesleyan University, high honors in Economics. Board has determined he is independent under Nasdaq and SEC rules .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Morgan Stanley International | Managing Director; Head of European Capital Markets Execution; Investment Banking COO | 1987–2006 | Member, Equity and Capital Commitment Committees; European Executive Committee; advised on >$100B IPOs/new issues/monetizations |
| White & Case LLP | Associate Attorney | Pre-1987 | Legal training; foundational corporate/finance experience |
| Perella Weinberg Partners | Partner; COO/Head of Capital Markets Advisory; Senior Adviser | Partner 2007 onward; Senior Adviser since 2016 | Management Committee; Executive Committee; capital markets/M&A advisory |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Perella Weinberg Partners | Senior Adviser (capital markets/M&A) | Since 2016 | Formerly Partner; COO/Head of Capital Markets Advisory |
No other public company directorships for Mr. Landman are disclosed in the proxy .
Board Governance
- Independence: Determined independent (with exception of CEO Leasure and CSO Sagartz) .
- Committee assignments: Chair, Compensation Committee (members: Landman (Chair), Brown, Coelho, Harrington, Neff) .
- Attendance/engagement: No director attended <75% of Board/committee meetings; all directors attended 2024 annual meeting; FY2024 meetings: Board 18; Compensation 6; Audit 7; Nominating/Gov 4 .
- Shareholder support: Elected March 14, 2024 as Class III director (For: 7,764,806; Withheld: 820,754; Broker non-votes: 6,536,635) .
- Risk oversight: Compensation Committee covers compensation risk, HCM (talent, DEI, pay equity), and mitigation policies (ownership guidelines/share retention/clawbacks authority) .
- Board leadership: Independent Chair (R. Matthew Neff); split CEO/Chair roles .
Fixed Compensation
| Metric | FY2023 | FY2024 |
|---|---|---|
| Cash fees paid | $47,833 | $70,000 |
| Board retainer (annual schedule) | $55,000 | $55,000 |
| Compensation Committee Chair retainer (annual schedule) | $15,000 | $15,000 |
| Total cash + equity (reported) | $157,835 | $114,275 |
Notes:
- Non-employee director cash retainer schedule unchanged YoY (Board $55k; Comp Chair $15k; Audit Chair $20k; Nominating Chair $10k; member fees vary) .
- Company has not adopted non-employee director stock ownership guidelines (alignment consideration) .
Performance Compensation
| Award Type | Grant Date | Shares | Grant Date Fair Value | Vesting |
|---|---|---|---|---|
| RSU (annual director grant) | Apr 1, 2023 | 25,822 | $110,002 | Vests on 1st anniversary (time-based) |
| RSU (annual director grant) | Aug 10, 2024 | 27,500 | $44,275 | Vests Mar 31, 2025 (time-based) |
Plan features affecting directors:
- Double-trigger vesting on change-in-control; annual non-employee director compensation cap $500,000; no option/SAR repricing without shareholder approval; no excise tax gross-up; no evergreen .
Performance metrics: No performance-based metrics were disclosed for director RSU grants; awards are time-based .
Beginning FY2025, directors may defer settlement of annual RSU awards (deferral flexibility) .
Other Directorships & Interlocks
| Entity | Nature | Potential Interlock/Conflict |
|---|---|---|
| Jermyn Street designation | Landman was designated to replace Jermyn Street’s prior designee in Jan 2023 under Envigo Shareholders Agreement | Board rights of Nominating Holders terminated after falling below 5% (last holder <5% filed Apr 3, 2024) . Board still deems Landman independent . |
Expertise & Qualifications
- Capital markets and M&A advisory across Health Care, Financials, Consumer, Telecom, Industrials; advised governments/boards/shareholders on >$100B of IPOs/new issues/monetizations .
- Legal/finance credentials (J.D./M.B.A., University of Chicago); economics (A.B., Wesleyan, high honors) .
- Executive committee/operating leadership experience at PWP and Morgan Stanley .
Equity Ownership
| Item | Value |
|---|---|
| Beneficial ownership (common shares) | 149,351; less than 1% of outstanding |
| Shares outstanding reference | 33,717,962 (Jan 14, 2025) |
| RSUs held as of Sep 30, 2024 | 27,500; options 0 |
| Anti-pledging/hedging | Directors prohibited from pledging, short sales, derivatives/hedging, and most pre-arranged transactions (except approved 10b5-1) |
Governance Assessment
-
Strengths
- Independent director with deep capital markets experience; chairs Compensation Committee overseeing pay risk, HCM, and compensation governance (including clawback/ownership policies) .
- Strong shareholder support on election (over 7.7M votes For) .
- Equity plan governance: double trigger CoC protections; no repricing; annual director award cap; no excise tax gross-up .
-
Alignment/Engagement Indicators
- Annual director RSU grants create equity linkage; FY2024 RSUs vest Mar 31, 2025; deferral election available from FY2025 .
- Attendance thresholds met; full attendance at 2024 meeting; active committee cadence (6 Compensation meetings in FY2024) .
-
RED FLAGS / Watch items
- No stock ownership guidelines for non-employee directors; potential alignment gap relative to best practices .
- Section 16(a) timeliness: Landman (among others) filed one Form 4 one or two days late for annual equity awards; minor but worth monitoring for compliance rigor .
- Initial appointment via major shareholder designation (Jermyn Street); rights since terminated as holder fell below 5%, but origin may warrant periodic independence reassessment .
Compensation Committee Analysis
| Attribute | Details |
|---|---|
| Composition | Landman (Chair), Brown, Coelho, Harrington, Neff |
| Meetings (FY2024) | 6 |
| Consultant | Meridian Compensation Partners (independent; market assessments for 2024–2025) |
| Scope | Executive pay design/approval; equity/incentive plans; compensation risk oversight; HCM programs (talent, DEI, pay equity); adoption/admin of ownership/clawback/risk-mitigation policies |
Director Compensation Structure
| Component | Policy / Amount |
|---|---|
| Board cash retainer (annual) | $55,000 |
| Committee chair retainers | Audit $20,000; Compensation $15,000; Nominating/Gov $10,000 |
| Committee member retainers | Audit $10,000; Compensation $7,500; Nominating/Gov $5,000 |
| Equity | Annual RSUs (FY2023: 25,822 RSUs vesting in 1 year; FY2024: 27,500 RSUs vesting Mar 31, 2025) |
| Ownership guidelines | None for non-employee directors |
| Business expenses | Reimbursed; governance education encouraged and reimbursed |
Related Party Transactions
- Audit Committee oversees related-party transactions policy; no specific related-party transactions disclosed for Mr. Landman .
Say-on-Pay & Shareholder Feedback
- Company conducts Say-on-Pay votes on a three-year cadence; Board recommends “THREE YEARS” frequency in 2025 . (2024 meeting did not include Say-on-Pay; approved the 2024 Equity Incentive Plan) .
Equity Plan Protections Relevant to Directors
- Annual non-employee director cap of $500,000 in aggregate grant-date fair value .
- No evergreen; no discounted option/SAR grants; dividend restrictions; double-trigger CoC vesting; anti-repricing without shareholder approval; no excise tax gross-ups .
Summary Signals for Investors
- Governance effectiveness supported by independent leadership, active committee work, and pay-risk oversight; Landman’s capital markets background adds transactional discipline .
- Alignment is moderated by time-based RSUs; absence of director ownership guidelines is a notable gap for long-term alignment; consider engaging on adopting guidelines .
- Compliance appears adequate; minor late Form 4 filings noted; origin via shareholder designation is no longer structurally binding post-termination of nominating rights .